Interleukin gene polymorphisms in pneumoconiosis
Simone Helmig1, Martin Grossmann, Jelena Wübbeling
1Institute and Polyclinic for Occupational and Social Medicine, Justus-Liebig University, D-35392 Giessen, Germany. simone.helming@arbmed.med.uni-giessend.de
International Journal of Molecular Medicine
|May 15, 2012
Summary
This study investigated interleukin gene polymorphisms and their link to asbestos or silica-induced lung diseases. The findings did not show a significant association between these polymorphisms and the development of such conditions.
Area of Science:
- Environmental Health
- Immunogenetics
- Pulmonary Medicine
Background:
- Inhaled asbestos fibers cause lung fibrosis and cancers through inflammation.
- Interleukins (IL), including IL-1β, IL-6, and IL-10, regulate inflammatory and proliferative responses to inhaled dusts like silica and asbestos.
- Genetic variations (polymorphisms) in interleukin genes may influence susceptibility to asbestos- and silica-induced lung diseases.
Purpose of the Study:
- To investigate the association between specific interleukin gene polymorphisms (IL-1β, IL-6, IL-10) and the risk of developing asbestos or silica-induced lung diseases.
- To determine if these polymorphisms are linked to fibrosis, lung cancer, or malignant mesothelioma in individuals exposed to asbestos or silica.
Main Methods:
- Association study conducted on 1180 individuals, including controls, fibrosis patients, lung cancer patients, and malignant mesothelioma patients.
- Investigated polymorphisms: IL-1β (C-511T; C+3954T), IL-6 (G-174C), and IL-10 (G-1082A).
- Compared allele frequencies between patient groups and a healthy control group to assess risk.
Main Results:
- Malignant mesothelioma patients showed a higher risk across all investigated polymorphisms compared to controls.
- The IL-6 -174C allele indicated a trend towards higher risk for fibrosis and asbestos-induced lung cancer.
- The IL-10 -1082A allele suggested a potential increased risk for silicosis, but not asbestosis.
Conclusions:
- The study did not find sufficient evidence to establish a significant association between the investigated interleukin polymorphisms and asbestos or silica-induced lung diseases in the studied population.
- While some trends were observed, particularly for IL-6 and IL-10, further research with larger cohorts may be needed to confirm these findings.
More Related Videos
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...